Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.

The epidermal growth factor receptor (EGFR) plays a key role in regulating cell proliferation, migration, and differentiation, and aberrant EGFR signaling is implicated in a variety of cancers. EGFR signaling is triggered by extracellular ligand binding, which promotes EGFR dimerization and activati...

Full description

Bibliographic Details
Main Authors: Anton Arkhipov, Yibing Shan, Eric T Kim, David E Shaw
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-07-01
Series:PLoS Computational Biology
Online Access:http://europepmc.org/articles/PMC4109842?pdf=render
id doaj-41547bf4a9564e2098e2a59699e24ac1
record_format Article
spelling doaj-41547bf4a9564e2098e2a59699e24ac12020-11-25T02:19:18ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582014-07-01107e100374210.1371/journal.pcbi.1003742Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.Anton ArkhipovYibing ShanEric T KimDavid E ShawThe epidermal growth factor receptor (EGFR) plays a key role in regulating cell proliferation, migration, and differentiation, and aberrant EGFR signaling is implicated in a variety of cancers. EGFR signaling is triggered by extracellular ligand binding, which promotes EGFR dimerization and activation. Ligand-binding measurements are consistent with a negatively cooperative model in which the ligand-binding affinity at either binding site in an EGFR dimer is weaker when the other site is occupied by a ligand. This cooperativity is widely believed to be central to the effects of ligand concentration on EGFR-mediated intracellular signaling. Although the extracellular portion of the human EGFR dimer has been resolved crystallographically, the crystal structures do not reveal the structural origin of this negative cooperativity, which has remained unclear. Here we report the results of molecular dynamics simulations suggesting that asymmetrical interactions of the two binding sites with the membrane may be responsible (perhaps along with other factors) for this negative cooperativity. In particular, in our simulations the extracellular domains of an EGFR dimer spontaneously lay down on the membrane in an orientation in which favorable membrane contacts were made with one of the bound ligands, but could not be made with the other. Similar interactions were observed when EGFR was glycosylated, as it is in vivo.http://europepmc.org/articles/PMC4109842?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Anton Arkhipov
Yibing Shan
Eric T Kim
David E Shaw
spellingShingle Anton Arkhipov
Yibing Shan
Eric T Kim
David E Shaw
Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
PLoS Computational Biology
author_facet Anton Arkhipov
Yibing Shan
Eric T Kim
David E Shaw
author_sort Anton Arkhipov
title Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
title_short Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
title_full Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
title_fullStr Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
title_full_unstemmed Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
title_sort membrane interaction of bound ligands contributes to the negative binding cooperativity of the egf receptor.
publisher Public Library of Science (PLoS)
series PLoS Computational Biology
issn 1553-734X
1553-7358
publishDate 2014-07-01
description The epidermal growth factor receptor (EGFR) plays a key role in regulating cell proliferation, migration, and differentiation, and aberrant EGFR signaling is implicated in a variety of cancers. EGFR signaling is triggered by extracellular ligand binding, which promotes EGFR dimerization and activation. Ligand-binding measurements are consistent with a negatively cooperative model in which the ligand-binding affinity at either binding site in an EGFR dimer is weaker when the other site is occupied by a ligand. This cooperativity is widely believed to be central to the effects of ligand concentration on EGFR-mediated intracellular signaling. Although the extracellular portion of the human EGFR dimer has been resolved crystallographically, the crystal structures do not reveal the structural origin of this negative cooperativity, which has remained unclear. Here we report the results of molecular dynamics simulations suggesting that asymmetrical interactions of the two binding sites with the membrane may be responsible (perhaps along with other factors) for this negative cooperativity. In particular, in our simulations the extracellular domains of an EGFR dimer spontaneously lay down on the membrane in an orientation in which favorable membrane contacts were made with one of the bound ligands, but could not be made with the other. Similar interactions were observed when EGFR was glycosylated, as it is in vivo.
url http://europepmc.org/articles/PMC4109842?pdf=render
work_keys_str_mv AT antonarkhipov membraneinteractionofboundligandscontributestothenegativebindingcooperativityoftheegfreceptor
AT yibingshan membraneinteractionofboundligandscontributestothenegativebindingcooperativityoftheegfreceptor
AT erictkim membraneinteractionofboundligandscontributestothenegativebindingcooperativityoftheegfreceptor
AT davideshaw membraneinteractionofboundligandscontributestothenegativebindingcooperativityoftheegfreceptor
_version_ 1724876947711852544